Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presen...

Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presentation Nears  Yahoo Finance

Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug - BioSpace

Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug  BioSpace

Exclusive: Arcturus raises $2.3M to make 3D immersive replays for live sports - Axios

Exclusive: Arcturus raises $2.3M to make 3D immersive replays for live sports  Axios

Arcturus' stock halves after mRNA therapy fails to evoke efficacy in cystic fibrosis trial - Fier...

Arcturus' stock halves after mRNA therapy fails to evoke efficacy in cystic fibrosis trial  Fierce Biotech

Arcturus! - WAMC

Arcturus!  WAMC

This Biotech, Up 188% Since April, Just Crashed 50%. Here's Why. - Investor's Business Daily

This Biotech, Up 188% Since April, Just Crashed 50%. Here's Why.  Investor's Business Daily

Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program - Business Wire

Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program  Business Wire

2025, November 9: Morning Moon Near Jupiter; Venus, Spica, and Arcturus in Twilight - When the Cu...

2025, November 9: Morning Moon Near Jupiter; Venus, Spica, and Arcturus in Twilight  When the Curves Line Up

The ARCTURUS Computer Developed At Sydney University In The 1960s - Hackaday

The ARCTURUS Computer Developed At Sydney University In The 1960s  Hackaday

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdin...

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm  PR Newswire

Arcturus: A distinguished amphibian in the history of Coast Guard aviation - United States Coast ...

Arcturus: A distinguished amphibian in the history of Coast Guard aviation  United States Coast Guard (.mil)

Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline  Yahoo Finance

Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Busin...

Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress  Business Wire

Arcturus stops work on early-stage vaccine programs in effort to 'streamline resources' - Fierce ...

Arcturus stops work on early-stage vaccine programs in effort to 'streamline resources'  Fierce Biotech

Arcturus Therapeutics to Attend Upcoming Investor Conferences - Business Wire

Arcturus Therapeutics to Attend Upcoming Investor Conferences  Business Wire

How Recent Shifts Are Rewriting the Story for Arcturus Therapeutics Holdings - Yahoo Finance

How Recent Shifts Are Rewriting the Story for Arcturus Therapeutics Holdings  Yahoo Finance

Arcturus Therapeutics (ARCT) Moves 7.7% Higher: Will This Strength Last? - Yahoo Finance

Arcturus Therapeutics (ARCT) Moves 7.7% Higher: Will This Strength Last?  Yahoo Finance

Arcturus Therapeutics (ARCT) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Fi...

Arcturus Therapeutics (ARCT) is on the Move, Here's Why the Trend Could be Sustainable  Yahoo Finance

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates  Yahoo Finance

Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress - Yaho...

Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress  Yahoo Finance

Zacks.com featured highlights include Flux Power, Aura Minerals, Arcturus Therapeutics and Sterli...

Zacks.com featured highlights include Flux Power, Aura Minerals, Arcturus Therapeutics and Sterling Infrastructure  Yahoo Finance

Arcturus Plunges 55.79% After Interim Phase 2 CF Data - Nasdaq

Arcturus Plunges 55.79% After Interim Phase 2 CF Data  Nasdaq

Piper Sandler Maintains Arcturus Therapeutics Holdings (ARCT) Overweight Recommendation - Nasdaq

Piper Sandler Maintains Arcturus Therapeutics Holdings (ARCT) Overweight Recommendation  Nasdaq

Arcturus Closes US$2.3M Funding Round - Entrevestor

Arcturus Closes US$2.3M Funding Round  Entrevestor

Citigroup Maintains Arcturus Therapeutics Holdings (ARCT) Neutral Recommendation - Nasdaq

Citigroup Maintains Arcturus Therapeutics Holdings (ARCT) Neutral Recommendation  Nasdaq

The Market Doesn't Like What It Sees From Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Rev...

The Market Doesn't Like What It Sees From Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Revenues Yet As Shares Tumble 52%  simplywall.st

Is Arcturus Therapeutics Stock Built to Withstand More Downside? - Trefis

Is Arcturus Therapeutics Stock Built to Withstand More Downside?  Trefis

CEO Has Led Arcturus Therapeutics Through 12 Eventful Years - San Diego Business Journal

CEO Has Led Arcturus Therapeutics Through 12 Eventful Years  San Diego Business Journal

Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross? - Zacks Investment Research

Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?  Zacks Investment Research

Arcturus Therapeutics Stock Plunges Over 58% Today: What’s Causing The Sell-Off? - Stocktwits

Arcturus Therapeutics Stock Plunges Over 58% Today: What’s Causing The Sell-Off?  Stocktwits

Arcturus Therapeutics: CF Setback Reinforces The Risks Of Its mRNA Therapeutics (ARCT) - Seeking ...

Arcturus Therapeutics: CF Setback Reinforces The Risks Of Its mRNA Therapeutics (ARCT)  Seeking Alpha

Arcturus Therapeutics (ARCT): Evaluating Valuation After Cystic Fibrosis Trial Setback and Height...

Arcturus Therapeutics (ARCT): Evaluating Valuation After Cystic Fibrosis Trial Setback and Heightened Regulatory Scrutiny  simplywall.st

Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies - BioSpace

Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies  BioSpace

Arcturus Sues AbbVie, Capstan Alleging Trade Secret Theft - Law360

Arcturus Sues AbbVie, Capstan Alleging Trade Secret Theft  Law360

Arcturus cut to Neutral at Citi on data for mRNA candidate - Seeking Alpha

Arcturus cut to Neutral at Citi on data for mRNA candidate  Seeking Alpha

Charting New Waters: The Scientific Legacy of the Women of the Arcturus Expedition | Blog | Natur...

Charting New Waters: The Scientific Legacy of the Women of the Arcturus Expedition | Blog | Nature  PBS

Wall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Pla...

Wall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Placing a Bet  Yahoo Finance

Emperor, 1349, Arcturus and more announced as part of initial lineup for Beyond The Gates 2026 - ...

Emperor, 1349, Arcturus and more announced as part of initial lineup for Beyond The Gates 2026  Lambgoat

Why Is Arcturus Therapeutics Stock (ARCT) Down 55% Today? - TipRanks

Why Is Arcturus Therapeutics Stock (ARCT) Down 55% Today?  TipRanks

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ....

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ...  Yahoo Finance

Arcturus Therapeutics Announces CFO Departure and Replacement - TipRanks

Arcturus Therapeutics Announces CFO Departure and Replacement  TipRanks

Arcturus Therapeutics: High Hopes, High Hurdles For Its mRNA Pipeline (ARCT) - Seeking Alpha

Arcturus Therapeutics: High Hopes, High Hurdles For Its mRNA Pipeline (ARCT)  Seeking Alpha

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Tr...

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade  Yahoo Finance

Arcturus Therapeutics Earnings Call: Progress Amid Challenges - TipRanks

Arcturus Therapeutics Earnings Call: Progress Amid Challenges  TipRanks

EMPEROR Feat. MORTIIS And FAUST, 1349, ARCTURUS Among First Acts Confirmed For Beyond The Gates 2...

EMPEROR Feat. MORTIIS And FAUST, 1349, ARCTURUS Among First Acts Confirmed For Beyond The Gates 2026  BraveWords

Arcturus Therapeutics Holdings Inc earnings missed by $6.02, revenue fell short of estimates - In...

Arcturus Therapeutics Holdings Inc earnings missed by $6.02, revenue fell short of estimates  Investing.com

Follow the Arc to Arcturus … - Mid-Island Times

Follow the Arc to Arcturus …  Mid-Island Times

Dennis Mammana: Follow the Arc to Arcturus with Spring Stargazing - Noozhawk

Dennis Mammana: Follow the Arc to Arcturus with Spring Stargazing  Noozhawk

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candid...

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1  BioSpace

Hercules is between 2 bright stars: Vega and Arcturus - EarthSky

Hercules is between 2 bright stars: Vega and Arcturus  EarthSky

Arcturus Therapeutics Holdings Inc expected to post a loss of 82 cents a share - Earnings Preview...

Arcturus Therapeutics Holdings Inc expected to post a loss of 82 cents a share - Earnings Preview  TradingView

Arcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal year - Investing.com

Arcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal year  Investing.com

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - Yahoo Finance

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate  Yahoo Finance

Arcturus Therapeutics Holdings Inc. Securities Lawsuit Investigation - Claim Depot

Arcturus Therapeutics Holdings Inc. Securities Lawsuit Investigation  Claim Depot

Is Arcturus Therapeutics (ARCT) a Worst High-Risk High-Reward Growth Stock to Buy? - Yahoo Finance

Is Arcturus Therapeutics (ARCT) a Worst High-Risk High-Reward Growth Stock to Buy?  Yahoo Finance

One person shot near 8th Street & Arcturus Drive in Colorado Springs - KRDO

One person shot near 8th Street & Arcturus Drive in Colorado Springs  KRDO

Spring Triangle in the east at night, heralding the season - EarthSky

Spring Triangle in the east at night, heralding the season  EarthSky

Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles - Markets Mojo

Arcturus Therapeutics Hits 52-Week Low at $7.26 Amid Financial Struggles  Markets Mojo

Brightest star in the sky? Find out which star is brightest tonight - BBC Sky at Night Magazine

Brightest star in the sky? Find out which star is brightest tonight  BBC Sky at Night Magazine

Arcturus Therapeutics Stock Faces Mounting Pressure Amid Strategic Shift - AD HOC NEWS

Arcturus Therapeutics Stock Faces Mounting Pressure Amid Strategic Shift  AD HOC NEWS

UPDATED: CEFC, La Caisse ag-carbon platform buys CQ’s Arcturus Downs - Grain Central

UPDATED: CEFC, La Caisse ag-carbon platform buys CQ’s Arcturus Downs  Grain Central

European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying ...

European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine  PR Newswire

Analysts Have Lowered Expectations For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) After It...

Analysts Have Lowered Expectations For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) After Its Latest Results  simplywall.st

Arcturus Therapeutics Stock Soars on Strong Financials and Pipeline Progress () - aktiencheck.de

Arcturus Therapeutics Stock Soars on Strong Financials and Pipeline Progress ()  aktiencheck.de

EC approves CSL and Arcturus’ Kostaive - The Pharma Letter

EC approves CSL and Arcturus’ Kostaive  The Pharma Letter

Arcturus and CSL Take on Pfizer With Longer-Lasting COVID Vaccine - Citeline News & Insights

Arcturus and CSL Take on Pfizer With Longer-Lasting COVID Vaccine  Citeline News & Insights

Arcturus Therapeutics launches Phase I Avian Influenza trials in US - Clinical Trials Arena

Arcturus Therapeutics launches Phase I Avian Influenza trials in US  Clinical Trials Arena

Arcturus Launches H5N1 Vaccine Trial as Cases Rise in US - Contagion Live

Arcturus Launches H5N1 Vaccine Trial as Cases Rise in US  Contagion Live

Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” - Gavi, the Vaccine Alliance

Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest”  Gavi, the Vaccine Alliance

What to Know About 'Arcturus,' the Latest COVID Variant - AARP

What to Know About 'Arcturus,' the Latest COVID Variant  AARP

Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism - The G...

Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism  The Globe and Mail

Arcturus’ COVID-19 Vaccine Triggers Enhanced Immune Response - Inside Precision Medicine

Arcturus’ COVID-19 Vaccine Triggers Enhanced Immune Response  Inside Precision Medicine

Arcturus in Boötes - BBC Sky at Night Magazine

Arcturus in Boötes  BBC Sky at Night Magazine

WHO watching XBB.1.16, dubbed Arcturus on social media, as a coronavirus variant of interest - cn...

WHO watching XBB.1.16, dubbed Arcturus on social media, as a coronavirus variant of interest  cnn.com

15-year-old boy fatally shot on Arcturus Lane - fox10tv.com

15-year-old boy fatally shot on Arcturus Lane  fox10tv.com

New COVID variant Arcturus XBB.1.16 may cause unusual symptoms in kids, docs say - TODAY.com

New COVID variant Arcturus XBB.1.16 may cause unusual symptoms in kids, docs say  TODAY.com

Singapore's co-developed vaccine candidate is in 'good shape' for delivery in 2021 - CNBC

Singapore's co-developed vaccine candidate is in 'good shape' for delivery in 2021  CNBC

Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, ...

Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults  PR Newswire

Arcturus: Facts About the 'Bear Guard' Star - Space

Arcturus: Facts About the 'Bear Guard' Star  Space

Aerovironment buys Arcturus UAV in $405M deal - Defense News

Aerovironment buys Arcturus UAV in $405M deal  Defense News

All You Need to Know About the Arcturus COVID-19 Variant - AdventHealth

All You Need to Know About the Arcturus COVID-19 Variant  AdventHealth

The 'Arcturus' COVID Variant Is Already in the Bay Area. What We Know About XBB.1.16 - KQED

The 'Arcturus' COVID Variant Is Already in the Bay Area. What We Know About XBB.1.16  KQED

What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye - unmc.edu

What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye  unmc.edu

Arcturus – Aspera Hiems Symfonia - Decibel Magazine

Arcturus – Aspera Hiems Symfonia  Decibel Magazine

What to know about XBB.1.16, the 'Arcturus' variant - NBC News

What to know about XBB.1.16, the 'Arcturus' variant  NBC News

Arcturus—a clinical-stage mRNA therapeutics and vaccines company - Nature

Arcturus—a clinical-stage mRNA therapeutics and vaccines company  Nature

What to know about Arcturus, a new coronavirus subvariant the WHO is tracking - The Washington Post

What to know about Arcturus, a new coronavirus subvariant the WHO is tracking  The Washington Post

What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye - Forbes

What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye  Forbes

Astranis officially announces UtilitySat to replace malfunctioning Arcturus satellite - Data Cent...

Astranis officially announces UtilitySat to replace malfunctioning Arcturus satellite  Data Center Dynamics

Arcturus: The Mysteries of the Red Giant Star - The Old Farmer’s Almanac

Arcturus: The Mysteries of the Red Giant Star  The Old Farmer’s Almanac

The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and L...

The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)  IPWatchdog.com

CSL Seqirus and Arcturus Ink $4.3 Billion mRNA Vaccine Deal - BioSpace

CSL Seqirus and Arcturus Ink $4.3 Billion mRNA Vaccine Deal  BioSpace

Life Sciences CEO Interview: Joe Payne, President and CEO of Arcturus Therapeutics - Mintz

Life Sciences CEO Interview: Joe Payne, President and CEO of Arcturus Therapeutics  Mintz

Halloween ghost of the summer sun - EarthSky

Halloween ghost of the summer sun  EarthSky

New COVID-19 strain: What to know about 'Arcturus' - Medical News Today

New COVID-19 strain: What to know about 'Arcturus'  Medical News Today

Astranis’ Arcturus Satellite Malfunctions - Payload Space

Astranis’ Arcturus Satellite Malfunctions  Payload Space

Lost In Time: Arcturus – The Sham Mirrors - The Progressive Subway -

Lost In Time: Arcturus – The Sham Mirrors  The Progressive Subway -

Arcturus JV scored $115M in Japanese grants to boost mRNA manufacturing - Fierce Pharma

Arcturus JV scored $115M in Japanese grants to boost mRNA manufacturing  Fierce Pharma

What to Know About the New COVID-19 Strain 'Arcturus' - Healthline

What to Know About the New COVID-19 Strain 'Arcturus'  Healthline

Meet Arcturus: Guardian of the Bear - Sky & Telescope

Meet Arcturus: Guardian of the Bear  Sky & Telescope